View ValuationEncres Dubuit 将来の成長Future 基準チェック /06現在、 Encres Dubuitの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長11.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報Price Target Changed • Nov 08Price target decreased to €4.40Down from €4.80, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €3.54. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of €0.047 for next year compared to €0.30 last year.Price Target Changed • Nov 01Price target lowered to €3.70Down from €4.10, the current price target is provided by 1 analyst. The new target price is 9.5% above the current share price of €3.38. As of last close, the stock is down 14% over the past year.Major Estimate Revision • Nov 01Analysts lower revenue estimates to €17.9mThe 2020 consensus revenue estimate decreased from €19.9m. Earnings per share (EPS) also decreased, with analysts lowering their estimates from -€0.41 to -€0.42 for the same period. The Chemicals industry in France is expected to see an average net income growth of 3.8% next year. The consensus price target was lowered from €4.10 to €3.70. Share price stayed mostly flat at €3.38 over the past week.すべての更新を表示Recent updatesお知らせ • May 19Encres Dubuit, Annual General Meeting, Jun 15, 2026Encres Dubuit, Annual General Meeting, Jun 15, 2026. Location: 1 rue isaac newton zi mitry compans, mitry mory FranceNew Risk • May 18New major risk - Revenue and earnings growthEarnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.32m market cap, or US$7.35m).New Risk • Dec 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Market cap is less than US$10m (€7.42m market cap, or US$8.65m). Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change).分析記事 • Sep 25Why Investors Shouldn't Be Surprised By Encres Dubuit's (EPA:ALDUB) Low P/SEncres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now compared...お知らせ • May 22Encres Dubuit, Annual General Meeting, Jun 26, 2025Encres Dubuit, Annual General Meeting, Jun 26, 2025. Location: 1 rue isaac newton, mitry mory FranceNew Risk • Mar 31New major risk - Revenue and earnings growthEarnings have declined by 51% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 51% per year over the past 5 years. Market cap is less than US$10m (€8.45m market cap, or US$9.14m).分析記事 • Mar 05Encres Dubuit (EPA:ALDUB) Surges 28% Yet Its Low P/S Is No Reason For ExcitementEncres Dubuit ( EPA:ALDUB ) shareholders would be excited to see that the share price has had a great month, posting a...分析記事 • Nov 13Encres Dubuit's (EPA:ALDUB) Share Price Boosted 28% But Its Business Prospects Need A Lift TooDespite an already strong run, Encres Dubuit ( EPA:ALDUB ) shares have been powering on, with a gain of 28% in the last...分析記事 • Sep 07Encres Dubuit's (EPA:ALDUB) Share Price Is Matching Sentiment Around Its RevenuesWith a price-to-sales (or "P/S") ratio of 0.4x Encres Dubuit ( EPA:ALDUB ) may be sending bullish signals at the...お知らせ • May 09Encres Dubuit, Annual General Meeting, Jun 13, 2024Encres Dubuit, Annual General Meeting, Jun 13, 2024. Location: zone industrielle de mitry compans, 1 rue isaac newton, mitry mory FranceReported Earnings • May 09Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in France.New Risk • Apr 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.72m). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (6.7% average weekly change).分析記事 • Apr 16Some Confidence Is Lacking In Encres Dubuit's (EPA:ALDUB) P/SThere wouldn't be many who think Encres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.5x is worth a...New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Market cap is less than US$10m (€9.25m market cap, or US$9.97m).Buying Opportunity • Dec 13Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €4.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Meanwhile, the company became loss making.Upcoming Dividend • Jun 19Upcoming dividend of €0.30 per share at 7.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 28 June 2023. Trailing yield: 7.4%. Within top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%).Price Target Changed • Nov 08Price target decreased to €4.40Down from €4.80, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €3.54. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of €0.047 for next year compared to €0.30 last year.Reported Earnings • Nov 03First half 2022 earnings released: EPS: €0.001 (vs €0.096 in 1H 2021)First half 2022 results: EPS: €0.001 (down from €0.096 in 1H 2021). Revenue: €11.1m (up 7.4% from 1H 2021). Net income: €4.0k (down 99% from 1H 2021). Profit margin: 0% (down from 2.8% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to €3.72, the stock trades at a forward P/E ratio of 76x. Average forward P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 26% over the past three years.分析記事 • Oct 13Returns On Capital At Encres Dubuit (EPA:ALDUB) Paint A Concerning PictureDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Reported Earnings • Jul 05Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €20.7m (up 11% from FY 2020). Net income: €905.0k (up €1.46m from FY 2020). Profit margin: 4.4% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.7%, compared to a 25% growth forecast for the industry in France.分析記事 • Feb 07These Return Metrics Don't Make Encres Dubuit (EPA:ALDUB) Look Too StrongIf we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...Reported Earnings • Oct 22First half 2021 earnings released: EPS €0.096 (vs €0.21 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €10.3m (up 19% from 1H 2020). Net income: €292.0k (up €950.0k from 1H 2020). Profit margin: 2.8% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 18New 90-day high: €4.40The company is up 18% from its price of €3.72 on 19 November 2020. The French market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 3.0% over the same period.Is New 90 Day High Low • Jan 19New 90-day high: €4.30The company is up 26% from its price of €3.42 on 21 October 2020. The French market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.Is New 90 Day High Low • Dec 18New 90-day high: €3.78The company is up 3.0% from its price of €3.66 on 18 September 2020. The French market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is down 3.0% over the same period.Price Target Changed • Nov 01Price target lowered to €3.70Down from €4.10, the current price target is provided by 1 analyst. The new target price is 9.5% above the current share price of €3.38. As of last close, the stock is down 14% over the past year.Major Estimate Revision • Nov 01Analysts lower revenue estimates to €17.9mThe 2020 consensus revenue estimate decreased from €19.9m. Earnings per share (EPS) also decreased, with analysts lowering their estimates from -€0.41 to -€0.42 for the same period. The Chemicals industry in France is expected to see an average net income growth of 3.8% next year. The consensus price target was lowered from €4.10 to €3.70. Share price stayed mostly flat at €3.38 over the past week.Is New 90 Day High Low • Oct 12New 90-day low: €3.48The company is down 9.0% from its price of €3.82 on 14 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 2.0% over the same period.Is New 90 Day High Low • Sep 18New 90-day low: €3.66The company is down 4.0% from its price of €3.80 on 19 June 2020. The French market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Encres Dubuit は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測ENXTPA:ALDUB - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202518-4-10N/A9/30/202518-3-1-1N/A12/31/202420-1-10N/A9/30/202420-1-10N/A6/30/202420-201N/A3/31/202420-2-10N/A12/31/202320-2-10N/A9/30/202321-2N/AN/AN/A6/30/202322-1-2-1N/A3/31/202322-1-10N/A12/31/2022230-10N/A9/30/2022220N/AN/AN/A6/30/2022211-10N/A3/31/202221100N/A12/31/202121101N/A9/30/202120111N/A6/30/202120012N/A3/31/202119012N/A12/31/202019-112N/A9/30/202019-111N/A6/30/202020-100N/A3/31/202022000N/A12/31/201924001N/A9/30/2019241N/A1N/A6/30/2019251N/A1N/A3/31/2019251N/A1N/A12/31/2018251N/A1N/A9/30/2018241N/A1N/A6/30/2018231N/A1N/A3/31/2018231N/A1N/A12/31/2017221N/A1N/A12/31/2016211N/A1N/A3/31/2016212N/A3N/A12/31/2015212N/A2N/A9/30/2015212N/A2N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ALDUBの予測収益成長が 貯蓄率 ( 2.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: ALDUBの収益がFrench市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: ALDUBの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: ALDUBの収益がFrench市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: ALDUBの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ALDUBの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 05:33終値2026/05/21 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Encres Dubuit 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Stephanie LefebvreGilbert DupontSandrine CauvinGilbert Dupont
Price Target Changed • Nov 08Price target decreased to €4.40Down from €4.80, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €3.54. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of €0.047 for next year compared to €0.30 last year.
Price Target Changed • Nov 01Price target lowered to €3.70Down from €4.10, the current price target is provided by 1 analyst. The new target price is 9.5% above the current share price of €3.38. As of last close, the stock is down 14% over the past year.
Major Estimate Revision • Nov 01Analysts lower revenue estimates to €17.9mThe 2020 consensus revenue estimate decreased from €19.9m. Earnings per share (EPS) also decreased, with analysts lowering their estimates from -€0.41 to -€0.42 for the same period. The Chemicals industry in France is expected to see an average net income growth of 3.8% next year. The consensus price target was lowered from €4.10 to €3.70. Share price stayed mostly flat at €3.38 over the past week.
お知らせ • May 19Encres Dubuit, Annual General Meeting, Jun 15, 2026Encres Dubuit, Annual General Meeting, Jun 15, 2026. Location: 1 rue isaac newton zi mitry compans, mitry mory France
New Risk • May 18New major risk - Revenue and earnings growthEarnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.32m market cap, or US$7.35m).
New Risk • Dec 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Market cap is less than US$10m (€7.42m market cap, or US$8.65m). Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change).
分析記事 • Sep 25Why Investors Shouldn't Be Surprised By Encres Dubuit's (EPA:ALDUB) Low P/SEncres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now compared...
お知らせ • May 22Encres Dubuit, Annual General Meeting, Jun 26, 2025Encres Dubuit, Annual General Meeting, Jun 26, 2025. Location: 1 rue isaac newton, mitry mory France
New Risk • Mar 31New major risk - Revenue and earnings growthEarnings have declined by 51% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 51% per year over the past 5 years. Market cap is less than US$10m (€8.45m market cap, or US$9.14m).
分析記事 • Mar 05Encres Dubuit (EPA:ALDUB) Surges 28% Yet Its Low P/S Is No Reason For ExcitementEncres Dubuit ( EPA:ALDUB ) shareholders would be excited to see that the share price has had a great month, posting a...
分析記事 • Nov 13Encres Dubuit's (EPA:ALDUB) Share Price Boosted 28% But Its Business Prospects Need A Lift TooDespite an already strong run, Encres Dubuit ( EPA:ALDUB ) shares have been powering on, with a gain of 28% in the last...
分析記事 • Sep 07Encres Dubuit's (EPA:ALDUB) Share Price Is Matching Sentiment Around Its RevenuesWith a price-to-sales (or "P/S") ratio of 0.4x Encres Dubuit ( EPA:ALDUB ) may be sending bullish signals at the...
お知らせ • May 09Encres Dubuit, Annual General Meeting, Jun 13, 2024Encres Dubuit, Annual General Meeting, Jun 13, 2024. Location: zone industrielle de mitry compans, 1 rue isaac newton, mitry mory France
Reported Earnings • May 09Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in France.
New Risk • Apr 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.72m). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (6.7% average weekly change).
分析記事 • Apr 16Some Confidence Is Lacking In Encres Dubuit's (EPA:ALDUB) P/SThere wouldn't be many who think Encres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.5x is worth a...
New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Market cap is less than US$10m (€9.25m market cap, or US$9.97m).
Buying Opportunity • Dec 13Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €4.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Meanwhile, the company became loss making.
Upcoming Dividend • Jun 19Upcoming dividend of €0.30 per share at 7.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 28 June 2023. Trailing yield: 7.4%. Within top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%).
Price Target Changed • Nov 08Price target decreased to €4.40Down from €4.80, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €3.54. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of €0.047 for next year compared to €0.30 last year.
Reported Earnings • Nov 03First half 2022 earnings released: EPS: €0.001 (vs €0.096 in 1H 2021)First half 2022 results: EPS: €0.001 (down from €0.096 in 1H 2021). Revenue: €11.1m (up 7.4% from 1H 2021). Net income: €4.0k (down 99% from 1H 2021). Profit margin: 0% (down from 2.8% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to €3.72, the stock trades at a forward P/E ratio of 76x. Average forward P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 26% over the past three years.
分析記事 • Oct 13Returns On Capital At Encres Dubuit (EPA:ALDUB) Paint A Concerning PictureDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Reported Earnings • Jul 05Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €20.7m (up 11% from FY 2020). Net income: €905.0k (up €1.46m from FY 2020). Profit margin: 4.4% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.7%, compared to a 25% growth forecast for the industry in France.
分析記事 • Feb 07These Return Metrics Don't Make Encres Dubuit (EPA:ALDUB) Look Too StrongIf we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Reported Earnings • Oct 22First half 2021 earnings released: EPS €0.096 (vs €0.21 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €10.3m (up 19% from 1H 2020). Net income: €292.0k (up €950.0k from 1H 2020). Profit margin: 2.8% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 18New 90-day high: €4.40The company is up 18% from its price of €3.72 on 19 November 2020. The French market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 3.0% over the same period.
Is New 90 Day High Low • Jan 19New 90-day high: €4.30The company is up 26% from its price of €3.42 on 21 October 2020. The French market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.
Is New 90 Day High Low • Dec 18New 90-day high: €3.78The company is up 3.0% from its price of €3.66 on 18 September 2020. The French market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is down 3.0% over the same period.
Price Target Changed • Nov 01Price target lowered to €3.70Down from €4.10, the current price target is provided by 1 analyst. The new target price is 9.5% above the current share price of €3.38. As of last close, the stock is down 14% over the past year.
Major Estimate Revision • Nov 01Analysts lower revenue estimates to €17.9mThe 2020 consensus revenue estimate decreased from €19.9m. Earnings per share (EPS) also decreased, with analysts lowering their estimates from -€0.41 to -€0.42 for the same period. The Chemicals industry in France is expected to see an average net income growth of 3.8% next year. The consensus price target was lowered from €4.10 to €3.70. Share price stayed mostly flat at €3.38 over the past week.
Is New 90 Day High Low • Oct 12New 90-day low: €3.48The company is down 9.0% from its price of €3.82 on 14 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 2.0% over the same period.
Is New 90 Day High Low • Sep 18New 90-day low: €3.66The company is down 4.0% from its price of €3.80 on 19 June 2020. The French market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.